Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain.
作者信息
Premkumar Madhumita, Reddy K Rajender
机构信息
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Gastro Hep Adv. 2023 Feb 17;2(4):547-548. doi: 10.1016/j.gastha.2023.02.005. eCollection 2023.
Abstract
摘要
相似文献
1
Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain.
Gastro Hep Adv. 2023 Feb 17;2(4):547-548. doi: 10.1016/j.gastha.2023.02.005. eCollection 2023.
2
MODIFIED TREATMENT OF HEPATORENAL SYNDROME TYPE I DEPENDING ON THE STAGE OF ACUTE KIDNEY INJURY.
Georgian Med News. 2021 May(314):125-128.
3
Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study.
Int J Nephrol. 2015;2015:108139. doi: 10.1155/2015/108139. Epub 2015 Jul 22.
4
Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
Ann Pharmacother. 2024 Feb;58(2):156-164. doi: 10.1177/10600280231177698. Epub 2023 Jun 4.
5
Hepatorenal Syndrome.
Clin J Am Soc Nephrol. 2019 May 7;14(5):774-781. doi: 10.2215/CJN.12451018. Epub 2019 Apr 17.
6
[Management of renal injury include hepatorenal syndrome in patients with decompensated liver cirrhosis].
Zhonghua Gan Zang Bing Za Zhi. 2020 May 20;28(5):381-385. doi: 10.3760/cma.j.cn501113-20200427-00216.
7
Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis.
JNMA J Nepal Med Assoc. 2020 Aug 31;58(228):554-559. doi: 10.31729/jnma.5147.
8
Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
Curr Opin Anaesthesiol. 2010 Apr;23(2):139-44. doi: 10.1097/ACO.0b013e32833724a8.
9
Hepatorenal syndrome: pathophysiology, diagnosis, and management.
BMJ. 2020 Sep 14;370:m2687. doi: 10.1136/bmj.m2687.
10
Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.
Adv Ther. 2023 Dec;40(12):5432-5446. doi: 10.1007/s12325-023-02674-z. Epub 2023 Oct 9.
引用本文的文献
1
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
Liver Transpl. 2024 Oct 1;30(10):1026-1038. doi: 10.1097/LVT.0000000000000399. Epub 2024 May 22.
本文引用的文献
1
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.
Aliment Pharmacol Ther. 2022 Oct;56(8):1284-1293. doi: 10.1111/apt.17195. Epub 2022 Aug 22.
2
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
Sci Rep. 2022 Apr 1;12(1):5503. doi: 10.1038/s41598-022-09505-1.
3
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
4
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
5
Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
Hepatology. 2020 Feb;71(2):600-610. doi: 10.1002/hep.30208. Epub 2019 Feb 20.
6
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.
7
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
Hepatology. 2016 Mar;63(3):983-92. doi: 10.1002/hep.28396. Epub 2016 Feb 3.
8
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
Hepatology. 2014 Sep;60(3):954-63. doi: 10.1002/hep.27006. Epub 2014 Jul 25.
9
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
Hepatology. 2010 Jan;51(1):219-26. doi: 10.1002/hep.23283.
Zotero 插件